Skip to main content
SpringerLink
Log in

Meningococcal vaccines: poor immunogenicity in the very young

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. WHO. Infectious diseases kill over 17 million people a year: WHO warns of global crisis. The world health report. Geneva: WHO, 1996. http://www.who.ch/programmes/whr/1996/pressl.htm

    Google Scholar 

  2. Kristiansen BE, Jenkins A. Preventing the spread of meningococcal infection: strategies for chemoprophylaxis. Dis Manage Health Outcomes 1997 May; 1(5): 233–40

    Article  Google Scholar 

  3. Peltola H. Meningococcal vaccines: current status and future possibilities. Drugs 1998 Mar; 55(3): 347–66

    Article  PubMed  CAS  Google Scholar 

  4. Whalen CM, Hockin JC, Ryan A, et al. The changing epidemiology of invasive meningococcal disease in Canada, 1985–1992: emergence of a virulent disease clone of Neiserria meningitidis. JAMA 1995; 273: 390–4

    Article  PubMed  CAS  Google Scholar 

  5. McLeod Griffiss J. Diseases caused by gram-negative bacteria. In: Isselbacher KJ, Martin JB, Braunwald E, et al., editors. Harrison’s principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994: 641–4

    Google Scholar 

  6. Treatment of bacterial meningitis relies on early identification and antibacterial therapy. Drug Ther Perspect 1994 Nov 28; 4(11): 8–10

    Google Scholar 

  7. Sierra GVG, Campa HC, Varcacel NM, et al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Annals 1991; 14: 195–210

    PubMed  CAS  Google Scholar 

  8. Bjune G, Højby EA, Grønnesby JK, et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991; 338: 1093–6

    Article  PubMed  CAS  Google Scholar 

  9. Mäkelä PH, Käyhty H, Weckström P, et al. Effect of group A meningococcal vaccine in army recruits in Finland. Lancet 1975; II: 883–6

    Article  Google Scholar 

  10. American Academy of Pediatrics. Meningococcal disease prevention and control strategies for practice-based physicians. Pediatrics 1996; 97: 404–11

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meningococcal vaccines: poor immunogenicity in the very young. Drugs Ther. Perspect 12, 11–13 (1998). https://doi.org/10.2165/00042310-199812070-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199812070-00004

Keywords

Search

Navigation